Improving Antibody Production in Stably Transfected CHO Cells by CRISPR‐Cas9‐Mediated Inactivation of Genes Identified in a Large‐Scale Screen with Chinese Hamster‐Specific siRNAs

Abstract The Chinese hamster ovary (CHO) cell line is commonly used for the production of biotherapeutics. As cell productivity directly affects the cost of production, methods are developed to manipulate the expression of specific genes that are known to be involved in protein synthesis, folding, and secretion to increase productivity. However, there are no large‐scale CHO‐specific functional screens to identify novel gene targets that impact the production of secreted recombinant proteins. Here, a large‐scale, CHO cell‐specific small interfering RNA screen is performed to identify genes that consistently enhance antibody production when silenced in a panel of seven CHO cell lines. Four genes, namely, Cyp1a2 , Atp5s, Dgki , and P3h2 , are identified, and then selected for CRISPR‐Cas9 knockout validation in recombinant CHO cell lines. Single knockout of Cyp1a2 , Atp5s , or Dgki , but not P3h2 , results in a more than 90% increase in specific antibody productivity. Overall, the knockout of Cyp1a2 demonstrates the most significant improvement of antibody production, with a minimal impact on cell growth.